恶性肿瘤中HOTAIRM1的调控作用及机制

基础医学与临床 ›› 2021, Vol. 41 ›› Issue (2): 262-266.

恶性肿瘤中HOTAIRM1的调控作用及机制

赵俞乔, 苏志雷, 崔云甫, 关沧海, 姜兴明^*

哈尔滨医科大学附属第二医院胆胰外科, 黑龙江哈尔滨 150086

收稿日期:2020-02-17 修回日期:2020-04-26 出版日期:2021-02-05 发布日期:2021-01-19
通讯作者: ^*xmjiang@hrbmu.edu.cn
基金资助:
国家自然科学基金(81602088)

Regulatory effects and mechanisms of HOTAIRM1 in malignant tumors

ZHAO Yu-qiao, SU Zhi-lei, CUI Yun-fu, GUAN Cang-hai, JIANG Xing-ming^*

Department of HPB Surgery, the 2nd Affiliated Hospital of Harbin Medical University, Harbin 150086, China

Received:2020-02-17 Revised:2020-04-26 Online:2021-02-05 Published:2021-01-19
Contact: ^*xmjiang@hrbmu.edu.cn

摘要/Abstract

摘要： HOTAIRM1是一种新近发现的长链非编码RNA(lncRNA),其在多种恶性肿瘤中呈现异常表达,并通过特定的信号传导途径调控mRNA、miRNA以及相应靶基因和靶蛋白,从而在肿瘤细胞的增殖、迁移、侵袭中起到重要作用。同时,HOTAIRM1与临床病理学和分子病理学密切相关,在患者的治疗和预后评估中也显现出巨大的潜力。

关键词: 长链非编码RNA, HOTAIRM1, 肿瘤, 调控作用

Abstract: HOTAIRM1, a newly found long non-coding RNA (lncRNA), is abnormally expressed in diverse malignant tumors, regulated mRNA, miRNA, relevant target gene or protein through specific signal transduction pathways to function in mechanisms of proliferation, invasion and metastasis of tumor cells. HOTAIRM1 is closely related to the clinicopathology or molecular pathology and have shown great potential in therapy and predicting prognosis of patients.

Key words: long non-coding RNA, HOTAIRM1, tumors, regulatory effects

中图分类号:

R730

赵俞乔, 苏志雷, 崔云甫, 关沧海, 姜兴明. 恶性肿瘤中HOTAIRM1的调控作用及机制[J]. 基础医学与临床, 2021, 41(2): 262-266.

ZHAO Yu-qiao, SU Zhi-lei, CUI Yun-fu, GUAN Cang-hai, JIANG Xing-ming. Regulatory effects and mechanisms of HOTAIRM1 in malignant tumors[J]. Basic & Clinical Medicine, 2021, 41(2): 262-266.

参考文献

[1] Mattick JS. Non-coding RNAs: the architects of eukaryotic complexity[J]. EMBO Rep, 2001, 2: 986-991.
[2] Kapranov P, Cheng J, Dike S, et al. RNA maps reveal new RNA classes and a possible function for pervasive transcription[J]. Science, 2007, 316: 1484-1488.
[3] 胡增涛, 徐书婉, 夏浩明, 等. KCNQ1OT1在肿瘤中的表达及意义[J]. 实用药物与临床, 2019, 22: 1226-1229.
[4] Xiao Y, Yan X, Yang Y, et al. Downregulation of long noncoding RNA HOTAIRM1 variant 1 contributes to osteoarthritis via regulating miR-125b/BMPR2 axis and activating JNK/MAPK/ERK pathway[J]. Biomed Pharmacother, 2019, 109: 1569-1577.
[5] Gharesouran J, Taheri M, Sayad A, et al. A novel regulatory function of long non-coding RNAs at different levels of gene expression in multiple sclerosis[J]. J Mol Neurosci, 2019, 67: 434-440.
[6] Qian C, Li H, Chang DQ, et al. Identification of functional lncRNAs in atrial fibrillation by integrative analysis of the lncRNA-mRNA network based on competing endogenous RNAs hypothesis[J]. J Cell Physiol, 2019, 234: 11620-11630.
[7] 王珊珊, 彭小忠, 韩为. HOTAIRM1调节OCT4表达维持胶质瘤干细胞的自我更新[J]. 基础医学与临床, 2019, 39: 792-797.
[8] Xia HP, Liu YH, Wang ZC, et al. Long noncoding RNA HOTAIRM1 maintains tumorigenicity of glioblastoma stem-like cells through regulation of HOX gene expression[J]. Neurotherapeutics, 2020,17:754-764.
[9] Hao YF, Li XL, Chen HH, et al. Over-expression of long noncoding RNA HOTAIRM1 promotes cell proliferation and invasion in human glioblastoma by up-regulating SP1 via sponging miR-137[J]. Neuroreport, 2020, 31: 109-117.
[10] Lin YH, Guo L, Yan F, et al. Long non-coding RNA HOTAIRM1 promotes proliferation and inhibits apoptosis of glioma cells by regulating the miR-873-5p/ZEB2 axis[J]. Chin Med J (Engl), 2020, 133: 174-182.
[11] Li Q, Dong CY, Cui JY, et al. Over-expressed lncRNA HOTAIRM1 promotes tumor growth and invasion through up-regulating HOXA1 and sequestering G9a/EZH2/Dnmts away from the HOXA1 gene in glioblastoma multiforme[J]. J Exp Clin Cancer Res, 2018, 37: 265-279.
[12] 李斌, 李娜, 刘家东, 等. 血清lncRNA HOTAIRM1在星型细胞瘤的诊断、预后预测的价值及靶基因预测[J]. 临床神经外科杂志, 2018, 15: 261-266.
[13] Liang QY, Li X, Guan GF, et al. Long non-coding RNA, HOTAIRM1, promotes glioma malignancy by forming a ceRNA network[J]. Aging, 2019, 11: 6805-6838.
[14] Zhang Y, Mi L, Xuan Y, et al. LncRNA HOTAIRM1 inhibits the progression of hepatocellular carcinoma by inhibiting the Wnt signaling pathway[J]. Eur Rev Med Pharmacol Sci, 2018, 22: 4861-4868.
[15] Ren TJ, Hou J, Liu CF, et al. The long non-coding RNA HOTAIRM1 suppresses cell progression via sponging endogenous miR-17-5p/B-cell translocation gene 3 (BTG3) axis in 5-fluorouracil resistant colorectal cancer cells[J]. Biomed Pharmacother, 2019, 117: 109171-109180.
[16] Wan LD, Kong JL, Tang JL, et al. HOTAIRM1 as a potential biomarker for diagnosis of colorectal cancer functions the role in the tumour suppressor[J]. J Cell Mol Med, 2016, 20: 2036-2044.
[17] Lu RQ, Zhao G, Yang YL, et al. Long noncoding RNA HOTAIRM1 inhibits cell progression by regulating miR-17-5p/PTEN axis in gastric cancer[J]. J Cell Biochem, 2019, 120: 4952-4965.
[18] Luo YY, He YQ, Ye XP, et al. High expression of long noncoding RNA HOTAIRM1 is associated with the proliferation and migration in pancreatic ductal adenocarcinoma[J]. Pathol Oncol Res, 2019, 25: 1567-1577.
[19] Li XL, Pang L, Yang Z, et al. LncRNA HOTAIRM1/HOXA1 axis promotes cell proliferation, migration and invasion in endometrial cancer[J]. Onco Targets Ther, 2019, 12: 10997-11015.
[20] Xiong F, Yin H, Zhang H, et al. Clinicopathologic features and the prognostic implications of long noncoding RNA HOTAIRM1 in non-small cell lung cancer[J]. Genet Test Mol Biomarkers, 2020, 24: 47-53.
[21] 李赟, 李勇, 巩平, 等. 髓源性免疫抑制细胞与晚期胃癌化疗疗效及预后的关系[J]. 基础医学与临床, 2020, 40: 235-237.
[22] Tian XY, Ma J, Wang T, et al. Long non-coding RNA HOXA transcript antisense RNA myeloid-specific 1-HOXA1 axis downregulates the immunosuppressive activity of myeloid-derived suppressor cells in lung cancer[J]. Front Immunol, 2018, 9: 473-484.
[23] Zheng M, Liu XG, Zhou Q, et al. HOTAIRM1 competed endogenously with miR-148a to regulate DLGAP1 in head and neck tumor cells[J]. Cancer Med, 2018, 7: 3143-3156.
[24] Hamilton MJ, Young M, Jang K, et al. HOTAIRM1 lncRNA is downregulated in clear cell renal cell carcinoma and inhibits the hypoxia pathway[J]. Cancer Lett, 2020, 472: 50-58.